Trials / Completed
CompletedNCT01929031
Efficacy and Safety of Ibuprofen and Caffeine in Dental Pain
A Single-centre, Double-blind, Randomised, Two-stage, Parallel-group Study to Assess the Efficacy and Safety of the Fixed Dose Combination of Ibuprofen 400 mg and Caffeine 100 mg Versus Ibuprofen 400 mg, Caffeine 100 mg and Placebo in Patients With Postoperative Dental Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 562 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to compare the efficacy of a combination product containing ibuprofen 400 mg and caffeine 100 mg versus either ingredient alone as well as placebo for the treatment of post-surgical dental pain over an eight-hour period followed by a single dose of study medication (study stage 1). A secondary objective is to evaluate efficacy of multiple doses of the combination in comparison to ibuprofen alone over a 5-day post-surgical period (study stage 2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ibuprofen + caffeine | FDC tablet |
| DRUG | ibuprofen | tablet. |
| DRUG | ibuprofen | tablet |
| DRUG | caffeine | tablet |
| DRUG | ibuprofen + caffeine | Fixed Dose Combination (FDC) tablet |
| DRUG | placebo | tablet |
| DRUG | placebo | tablet |
| DRUG | caffeine | tablet |
| DRUG | ibuprofen | tablet |
| DRUG | ibuprofen + caffeine | FDC tablet |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2013-08-27
- Last updated
- 2016-11-16
- Results posted
- 2016-11-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01929031. Inclusion in this directory is not an endorsement.